Effective elimination of cancer stem cells by magnetic hyperthermia

Molecular Pharmaceutics

Volumn 10, Issue 4, 2013, Pages 1432-1441

  Sadhukha, Tanmoy ^a   Niu, Lin ^a   Wiedmann, Timothy Scott ^a   Panyam, Jayanth ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

aldehyde dehydrogenase; cancer stem cells; clonogenicity; magnetic hyperthermia; mammosphere; necrosis; reactive oxygen species; superparamagnetic iron oxide; tumorigenicity

Indexed keywords

ALDEHYDE DEHYDROGENASE; MAGNETITE; REACTIVE OXYGEN METABOLITE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BATH; CANCER STEM CELL; CELL DEATH; CELL KILLING; CONTROLLED STUDY; FEMALE; HIGH TEMPERATURE; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IN VIVO STUDY; MAGNETIC FIELD; MAGNETIC HYPERTHERMIA; MAGNETISM; MOUSE; NONHUMAN; PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR RECURRENCE; XENOTRANSPLANTATION;

ALDEHYDE DEHYDROGENASE; ANIMALS; CELL LINE, TUMOR; FEMALE; FERRIC COMPOUNDS; HUMANS; HYPERTHERMIA, INDUCED; MAGNETICS; MAGNETITE NANOPARTICLES; MICE; MICE, INBRED BALB C; MICE, NUDE; NECROSIS; NEOPLASTIC STEM CELLS; PARTICLE SIZE; PHENOTYPE; REACTIVE OXYGEN SPECIES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TEMPERATURE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84875797745     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400015b     Document Type: Article

References (52)

1. Chandler, J. M.; Lagasse, E. Cancerous stem cells: deviant stem cells with cancer-causing misbehavior Stem Cell Res. Ther. 2010, 1 (2) 13
2. Potten, C. S.; Loeffler, M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt Development 1990, 110 (4) 1001-1020
3. Li, X.; Lewis, M. T.; Huang, J.; Gutierrez, C.; Osborne, C. K.; Wu, M. F.; Hilsenbeck, S. G.; Pavlick, A.; Zhang, X.; Chamness, G. C.; Wong, H.; Rosen, J.; Chang, J. C. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy J. Natl. Cancer Inst. 2008, 100 (9) 672-9
4. Moitra, K.; Lou, H.; Dean, M. Multidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic development Clin. Pharmacol. Ther. 2011, 89 (4) 491-502
5. Bao, S.; Wu, Q.; McLendon, R. E.; Hao, Y.; Shi, Q.; Hjelmeland, A. B.; Dewhirst, M. W.; Bigner, D. D.; Rich, J. N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 2006, 444 (7120) 756-760
6. Diehn, M.; Cho, R. W.; Lobo, N. A.; Kalisky, T.; Dorie, M. J.; Kulp, A. N.; Qian, D.; Lam, J. S.; Ailles, L. E.; Wong, M.; Joshua, B.; Kaplan, M. J.; Wapnir, I.; Dirbas, F. M.; Somlo, G.; Garberoglio, C.; Paz, B.; Shen, J.; Lau, S. K.; Quake, S. R.; Brown, J. M.; Weissman, I. L.; Clarke, M. F. Association of reactive oxygen species levels and radioresistance in cancer stem cells Nature 2009, 458 (7239) 780-3
7. Moore, N.; Lyle, S., Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J. Oncol. 2011, 2011.
8. Dylla, S. J.; Beviglia, L.; Park, I. K.; Chartier, C.; Raval, J.; Ngan, L.; Pickell, K.; Aguilar, J.; Lazetic, S.; Smith-Berdan, S.; Clarke, M. F.; Hoey, T.; Lewicki, J.; Gurney, A. L. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy PLoS One 2008, 3 (6) e2428
9. Dewhirst, M. W.; Prosnitz, L.; Thrall, D.; Prescott, D.; Clegg, S.; Charles, C.; MacFall, J.; Rosner, G.; Samulski, T.; Gillette, E.; LaRue, S. Hyperthermic treatment of malignant diseases: current status and a view toward the future Semin. Oncol. 1997, 24 (6) 616-25
10. Cotte, E.; Glehen, O.; Mohamed, F.; Lamy, F.; Falandry, C.; Golfier, F.; Gilly, F. N. Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients World J. Surg. 2007, 31 (9) 1813-20
11. van der Zee, J.; Gonzalez Gonzalez, D.; van Rhoon, G. C.; van Dijk, J. D.; van Putten, W. L.; Hart, A. A. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group Lancet 2000, 355 (9210) 1119-25
12. Atkinson, R. L.; Zhang, M.; Diagaradjane, P.; Peddibhotla, S.; Contreras, A.; Hilsenbeck, S. G.; Woodward, W. A.; Krishnan, S.; Chang, J. C.; Rosen, J. M. Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy Sci. Transl. Med. 2010, 2 (55) 55ra79
13. Tseng, H. Y.; Lee, G. B.; Lee, C. Y.; Shih, Y. H.; Lin, X. Z. Localised heating of tumours utilising injectable magnetic nanoparticles for hyperthermia cancer therapy IET Nanobiotechnol. 2009, 3 (2) 46-54
14. Maier-Hauff, K.; Ulrich, F.; Nestler, D.; Niehoff, H.; Wust, P.; Thiesen, B.; Orawa, H.; Budach, V.; Jordan, A. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme J. Neurooncol. 2011, 103 (2) 317-24
15. Johannsen, M.; Thiesen, B.; Jordan, A.; Taymoorian, K.; Gneveckow, U.; Waldofner, N.; Scholz, R.; Koch, M.; Lein, M.; Jung, K.; Loening, S. A. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model Prostate 2005, 64 (3) 283-92
16. Jones, S. K.; Winter, J. G.; Gray, B. N. Treatment of experimental rabbit liver tumours by selectively targeted hyperthermia Int. J. Hyperthermia 2002, 18 (2) 117-28
17. Jordan, A.; Scholz, R.; Maier-Hauff, K.; van Landeghem, F. K.; Waldoefner, N.; Teichgraeber, U.; Pinkernelle, J.; Bruhn, H.; Neumann, F.; Thiesen, B.; von Deimling, A.; Felix, R. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma J. Neurooncol. 2006, 78 (1) 7-14
18. Balivada, S.; Rachakatla, R. S.; Wang, H.; Samarakoon, T. N.; Dani, R. K.; Pyle, M.; Kroh, F. O.; Walker, B.; Leaym, X.; Koper, O. B.; Tamura, M.; Chikan, V.; Bossmann, S. H.; Troyer, D. L. A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: a mouse study BMC Cancer 2010, 10, 119
19. Jain, T. K.; Morales, M. A.; Sahoo, S. K.; Leslie-Pelecky, D. L.; Labhasetwar, V. Iron oxide nanoparticles for sustained delivery of anticancer agents Mol. Pharmaceutics 2005, 2 (3) 194-205
20. Tae-Youb, K.; Yamazaki, Y. Determination of the magnetic compensation composition in Al-substituted Bi-DyCoIG nanoparticles with enhanced coercive-force IEEE Trans. Magn. 2004, 40 (4) 2793-2795
21. Krishna Murti, G. S. R.; Moharir, A. V.; Sarma, V. A. K. Spectrophotometric determination of iron with orthophenanthroline Microchem. J. 1970, 15 (4) 585-589
22. Ho, M. M.; Ng, A. V.; Lam, S.; Hung, J. Y. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells Cancer Res. 2007, 67 (10) 4827-33
23. Sung, J.-M.; Cho, H.-J.; Yi, H.; Lee, C.-H.; Kim, H.-S.; Kim, D.-K.; Abd El-Aty, A. M.; Kim, J.-S.; Landowski, C. P.; Hediger, M. A.; Shin, H.-C. Characterization of a stem cell population in lung cancer A549 cells Biochem. Biophys. Res. Commun. 2008, 371 (1) 163-167
24. Grimshaw, M.; Cooper, L.; Papazisis, K.; Coleman, J.; Bohnenkamp, H.; Chiapero-Stanke, L.; Taylor-Papadimitriou, J.; Burchell, J. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells Breast Cancer Res. 2008, 10 (3) R52
25. Ginestier, C.; Hur, M. H.; Charafe-Jauffret, E.; Monville, F.; Dutcher, J.; Brown, M.; Jacquemier, J.; Viens, P.; Kleer, C. G.; Liu, S.; Schott, A.; Hayes, D.; Birnbaum, D.; Wicha, M. S.; Dontu, G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 2007, 1 (5) 555-567
26. Franken, N. A. P.; Rodermond, H. M.; Stap, J.; Haveman, J.; van Bree, C. Clonogenic assay of cells in vitro Nat. Protocols 2006, 1 (5) 2315-2319
27. He, L.; Yang, C. P.; Horwitz, S. B. Mutations in beta-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines Mol. Cancer Ther. 2001, 1 (1) 3-10
28. Croker, A. K.; Goodale, D.; Chu, J.; Postenka, C.; Hedley, B. D.; Hess, D. A.; Allan, A. L. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability J. Cell. Mol. Med. 2009, 13 (8B) 2236-52
29. Namduri, H.; Nasrazadani, S. Quantitative analysis of iron oxides using Fourier transform infrared spectrophotometry Corros. Sci. 2008, 50 (9) 2493-2497
30. Iliopoulos, D.; Hirsch, H. A.; Wang, G.; Struhl, K. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (4) 1397-402
31. Burke, A. R.; Singh, R. N.; Carroll, D. L.; Wood, J. C. S.; Dagostino, R. B., Jr.; Ajayan, P. M.; Torti, F. M.; Torti, S. V. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy Biomaterials 2012, 33 (10) 2961-2970
32. Korzeniewski, C.; Callewaert, D. M. An enzyme-release assay for natural cytotoxicity J. Immunol. Methods 1983, 64 (3) 313-20
33. Spagnuolo, G.; D'Anto, V.; Cosentino, C.; Schmalz, G.; Schweikl, H.; Rengo, S. Effect of N-acetyl-L-cysteine on ROS production and cell death caused by HEMA in human primary gingival fibroblasts Biomaterials 2006, 27 (9) 1803-9
34. Gilchrist, R. K.; Medal, R.; Shorey, W. D.; Hanselman, R. C.; Parrott, J. C.; Taylor, C. B. Selective inductive heating of lymph nodes Ann. Surg. 1957, 146 (4) 596-606
35. Kalambur, V. S.; Han, B.; Hammer, B. E.; Shield, T. W.; Bischof, J. C. In vitro characterization of movement, heating and visualization of magnetic nanoparticles for biomedical application Nanotechnology 2005, 16, 1221-33
36. Wada, S.; Tazawa, K.; Furuta, I.; Nagae, H. Antitumor effect of new local hyperthermia using dextran magnetite complex in hamster tongue carcinoma Oral Dis. 2003, 9 (4) 218-23
37. Liu, J.; Sun, Z.; Deng, Y.; Zou, Y.; Li, C.; Guo, X.; Xiong, L.; Gao, Y.; Li, F.; Zhao, D. Highly water-dispersible biocompatible magnetite particles with low cytotoxicity stabilized by citrate groups Angew. Chem., Int. Ed. Engl. 2009, 48 (32) 5875-9
38. Schulze, K.; Koch, A.; Petri-Fink, A.; Steitz, B.; Kamau, S.; Hottiger, M.; Hilbe, M.; Vaughan, L.; Hofmann, M.; Hofmann, H.; von Rechenberg, B. Uptake and biocompatibility of functionalized poly(vinylalcohol) coated superparamagnetic maghemite nanoparticles by synoviocytes in vitro J. Nanosci. Nanotechnol. 2006, 6 (9-10) 2829-40
39. Halbreich, A.; Roger, J.; Pons, J. N.; Geldwerth, D.; Da Silva, M. F.; Roudier, M.; Bacri, J. C. Biomedical applications of maghemite ferrofluid Biochimie 1998, 80 (5-6) 379-90
40. Corot, C.; Robert, P.; Idee, J. M.; Port, M. Recent advances in iron oxide nanocrystal technology for medical imaging Adv. Drug Delivery Rev. 2006, 58 (14) 1471-504
41. Rosensweig, R. E. Heating magnetic fluid with alternating magnetic field J. Magn. Magn. Mater. 2002, 252 (0) 370-374
42. Hergt, R.; Andra, W.; d'Ambly, C. G.; Hilger, I.; Kaiser, W. A.; Richter, U.; Schmidt, H. G. Physical limits of hyperthermia using magnetite fine particles IEEE Trans. Magn. 1998, 34 (5) 3745-3754
43. Heldin, C. H.; Rubin, K.; Pietras, K.; Ostman, A. High interstitial fluid pressure-an obstacle in cancer therapy Nat. Rev. Cancer 2004, 4 (10) 806-13
44. Rebodos, R. L.; Vikesland, P. J. Effects of oxidation on the magnetization of nanoparticulate magnetite Langmuir 2010, 26 (22) 16745-53
45. http://www.magforce.de/english/clinical-trials/overview.html.
46. Wehner, H.; von Ardenne, A.; Kaltofen, S. Whole-body hyperthermia with water-filtered infrared radiation: technical-physical aspects and clinical experiences Int. J. Hyperthermia 2001, 17 (1) 19-30
47. Issels, R. D.; Abdel-Rahman, S.; Wendtner, C.; Falk, M. H.; Kurze, V.; Sauer, H.; Aydemir, U.; Hiddemann, W. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study Eur. J. Cancer 2001, 37 (13) 1599-608
48. Charafe-Jauffret, E.; Ginestier, C.; Birnbaum, D. Breast cancer stem cells: tools and models to rely on BMC Cancer 2009, 9, 202
49. Krakstad, C.; Chekenya, M. Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics Mol. Cancer 2010, 9, 135
50. Festjens, N.; Vanden Berghe, T.; Vandenabeele, P. Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response Biochim. Biophys. Acta 2006, 1757 (9-10) 1371-87
51. Apopa, P. L.; Qian, Y.; Shao, R.; Guo, N. L.; Schwegler-Berry, D.; Pacurari, M.; Porter, D.; Shi, X.; Vallyathan, V.; Castranova, V.; Flynn, D. C. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling Part. Fibre Toxicol. 2009, 6, 1
52. Seton-Rogers, S. Cancer stem cells: Survival skills Nat. Rev. Cancer 2009, 9 (3) 147-147